You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis B virus surface antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)

Not yet recruiting
  • Resolved Hepatitis B
  • CD20 Positive B-cell Lymphoma
  • (no location specified)
Jul 10, 2022

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +12 more
Jan 17, 2023

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • standard hepatitis B vaccine
  • accelerated HBV Vaccine
  • (no location specified)
Jul 27, 2023

Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

Recruiting
  • Lung Transplant
  • Hepatitis B
  • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
  • Philadelphia, Pennsylvania
    Hospital of University of Pennsylvania
Oct 1, 2022

Hepatitis B Virus Reactivation:Cautionary Event After Liver

Completed
  • Liver Transplant; Complications
  • Diagnosis of postoperative recurrence of liver cancer
  • (no location specified)
Oct 27, 2023

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))

Withdrawn
  • Hepatitis B, Chronic
  • Entecavir (ETV)
  • +2 more
  • Kolding, Denmark
  • +29 more
Oct 27, 2022

Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

Not yet recruiting
  • Chronic Hepatitis B
  • (no location specified)
Feb 28, 2023

Hepatic Steatosis and Chronic Hepatitis B Virus

Not yet recruiting
  • Chronic Hepatitis
  • Liver biopsy
  • Sohag, Egypt
    Faculty of medicine
Dec 28, 2022

Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)

Recruiting
  • Hepatitis B, Chronic
  • pegylated interferon-alfa
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021

Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

Not yet recruiting
  • Cutaneous Warts
  • Hepatitis B Virus Vaccine(HBV)
  • (no location specified)
Jun 13, 2023

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Australian Hepatitis and Risk Survey in Prisons

Recruiting
  • Hepatitis C
  • +2 more
  • Point-of-care hepatitis C antibody test
  • +5 more
  • Hume, Australian Capital Territory, Australia
  • +23 more
Apr 20, 2023

Chronic Hepatitis B Trial in Beijing (TCR-T)

Active, not recruiting
  • Chronic Hepatitis B
  • TCR-T
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital
Jun 13, 2023

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hepatitis B Trial in Hanoi (Sci-B-Vac-Lot B, Sci-B-Vac-Lot A, Engerix-B)

    Completed
    Has Results
    • Hepatitis B
    • Sci-B-Vac-Lot B
    • +2 more
    • Hanoi, Vietnam
      National Institute of Hygiene and Epidemiology (NIHE)
    Jul 18, 2022

    Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

    Active, not recruiting
    • Hepatitis B
    • Baltimore, Maryland
    • +9 more
    Jan 17, 2023

    Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)

    Not yet recruiting
    • Chronic Hepatitis b
    • Rotterdam, Netherlands
      Erasmus MC
    Apr 21, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Chronic Hepatitis B Trial in Melbourne (162, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • 162
    • Placebo
    • Melbourne, Australia
      Nucleus Network Pty Ltd
    Jun 5, 2022

    Gut Microbiome in People Living With HIV and HBV

    Not yet recruiting
    • Human Immunodeficiency Virus
    • +2 more
      • (no location specified)
      Nov 8, 2023

      Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

      Not yet recruiting
      • Chronic Hepatitis b
      • Anti-PD-1 Antibody
      • Anti-PD-1 antibody
      • NAs
      • Chongqing, Chongqing, China
        The 2nd affiliated Hospital of Chongqing Medical University
      Mar 3, 2023